Browsing: Stocks
‘Don’t get suckered like I did’: I paid $185 to the wrong passport website. Can I get my money back?
“I will file a complaint with the Better Business Bureau.”
The chip company came up short on its bottom line.
Loadings at a Mediterranean port have picked up as Saudi Arabia races to offer its oil to buyers through a…
Sales outpace Wall Street expectations as defense business comes through while commercial airplane sales miss mark.
‘We are not romantically involved’: I’m marrying my platonic best friend of 20 years. Should I leave him my home?
“I own my home outright, have no children or other dependents.”
Oil prices sink, stock futures rally as U.S. and Iran pause attacks, Wall Street awaits busy week
U.S. stock-index futures rallied and oil prices tumbled on Sunday as the U.S. and Iran took a pause from fighting,…
‘Time will tell whether that was a good bet’: My adviser got me a full SpaceX IPO allocation. Was I lucky?
“Investors frequently receive only a small fraction of the shares they request — if they receive any at all.”
SpaceX isn’t the wireless threat that investors fear — unless someone breaks this unspoken agreement
It would likely be too expensive and time-consuming for SpaceX to build a mobile network on its own. But the…
As Washington considers tighter restrictions on open-weight AI over concerns of intellectual-property theft, Nvidia and other tech companies are pushing…
Most FDA advisers say peptides like BPC-157 and TB-500 should be made available in the U.S. Here’s what happens next.
The FDA is deciding whether seven peptides can be legally compounded, potentially opening the door to broader use in Americans.